| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT06441006 | Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis | Tuberculosis, Pulmonary | Recruiting |
| NCT04310930 | Finding the Optimal Regimen for Mycobacterium Abscessus Treatment | Pulmonary Disease Due to Mycobacteria (Diagnosis) | Recruiting |
| Phase 2 | |||
| NCT06921213 | Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis | Syphilis, Congenital | Recruiting |
| NCT06192160 | Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis | Pulmonary Tuberculosis | Recruiting |
| NCT05383742 | Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and… | Tuberculous Meningitis | Recruiting |
| NCT07372781 | Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium… | Monotherapy | Enrolling by Invitation |
| NCT07485010 | Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase… | Mycobacterium Abscessus Pulmonary Disease | Not Yet Recruiting |
| NCT03828201 | Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and… | Tuberculosis, Multidrug-Resistant | Active, Not Recruiting |
| Phase 1 | |||
| NCT07228702 | Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection | Non-Tuberculous Mycobacterial (NTM) Pneumonia | Enrolling by Invitation |
| Not specified | |||
| NCT06958835 | Linezolid Plus Standard of Care | Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) | Recruiting |